Abstract
Background: Diabetes Mellitus (DM) is a common medical condition affecting more than 6% of the world population. Besides well-known pathology like diabetic retinopathy and renal insufficiency, it carries important orthopedic implications, especially around the foot and ankle (diabetic foot).
Focus: This article focusses on the three major areas confronting the orthopedist: 1) changes in foot statics and biology leading to ulceration with or without osteomyelitis, 2) ankle fractures, particularly complications after a fracture and 3) Charcot foot.
Their pathophysiology, clinical features, classification, diagnostic dilemmas and treatment options are discussed.
Conclusion: DM is very common and is often associated with foot problems. Diabetic foot is a special condition that needs special attention. This article aims to provide the necessary knowledge to a better understanding and treatment of the diabetic foot.
Keywords: Diabetic foot, diabetes mellitus, orthopedic surgery, orthopedic shoe, charcot, neuropathy, ankle fracture.
Current Pharmaceutical Design
Title:Orthopedic Aspects of the Diabetic Foot
Volume: 24 Issue: 12
Author(s): Elvira J.A. Tijdens-Creusen, Paul C. Jutte*, Wim M.H.H. Schoumakers, Melanie M. Van der Klauw and Marjan Wouthuyzen-Bakker
Affiliation:
- Department of Orthopaedic Surgery, University of Groningen, University Medical Center Groningen, Groningen,Netherlands
Keywords: Diabetic foot, diabetes mellitus, orthopedic surgery, orthopedic shoe, charcot, neuropathy, ankle fracture.
Abstract: Background: Diabetes Mellitus (DM) is a common medical condition affecting more than 6% of the world population. Besides well-known pathology like diabetic retinopathy and renal insufficiency, it carries important orthopedic implications, especially around the foot and ankle (diabetic foot).
Focus: This article focusses on the three major areas confronting the orthopedist: 1) changes in foot statics and biology leading to ulceration with or without osteomyelitis, 2) ankle fractures, particularly complications after a fracture and 3) Charcot foot.
Their pathophysiology, clinical features, classification, diagnostic dilemmas and treatment options are discussed.
Conclusion: DM is very common and is often associated with foot problems. Diabetic foot is a special condition that needs special attention. This article aims to provide the necessary knowledge to a better understanding and treatment of the diabetic foot.
Export Options
About this article
Cite this article as:
Tijdens-Creusen J.A. Elvira, Jutte C. Paul *, Schoumakers M.H.H. Wim, Van der Klauw M. Melanie and Wouthuyzen-Bakker Marjan, Orthopedic Aspects of the Diabetic Foot, Current Pharmaceutical Design 2018; 24 (12) . https://dx.doi.org/10.2174/1381612824666180328120347
DOI https://dx.doi.org/10.2174/1381612824666180328120347 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part -II
Current Topics in Medicinal Chemistry Seeds of Mung Bean (<i>Vigna radiata</i> (L.) R.Wilczek): Taxonomy, Phytochemistry, Medicinal Uses and Pharmacology
Current Bioactive Compounds Enzymes as Target Antigens of Liver-Specific Autoimmunity: The Case of Cytochromes P450s
Current Medicinal Chemistry Diagnosis and Prognosis of Fetal Cardiomyopathies: A Review
Current Pharmaceutical Design Regenerative Medicine: Does Erythropoietin have a Role?
Current Pharmaceutical Design Cerebrovascular Complications of Diabetes: SGLT-2 Inhibitors as a Promising Future Therapeutics
Current Drug Targets Pentosidine, an Advanced Glycation Endproduct, and Arthritis
Current Rheumatology Reviews Carotid and Vertebral Arterial Variations in Alzheimer's Disease
Current Alzheimer Research Inflammatory Markers Associated With Diabetes Mellitus – Old and New Players
Current Pharmaceutical Design Role of Thrombin Activatable Fibrinolysis Inhibitor in Endocrine and Cardiovascular Disorders: An Update
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Hormones and the Autonomic Nervous System are Involved in Suprachiasmatic Nucleus Modulation of Glucose Homeostasis
Current Diabetes Reviews Halting Arterial Aging in Patients with Cardiovascular Disease: Hypolipidemic and Antihypertensive Therapy
Current Pharmaceutical Design Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
Current Pharmaceutical Design Clinical Features and Disease Damage Risk Factors in an Egyptian SLE Cohort: A Multicenter Study
Current Rheumatology Reviews Self-care improvement after a pharmaceutical intervention in elderly type 2 diabetic patients
Current Diabetes Reviews FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?
Current Diabetes Reviews Insulin Therapy in Pregnancy Hypertensive Diseases and its Effect on the Offspring and Mother Later in Life
Current Vascular Pharmacology Testosterone Replacement Therapy in Older Male Subjective Memory Complainers: Double-Blind Randomized Crossover Placebo-Controlled Clinical Trial of Physiological Assessment and Safety
CNS & Neurological Disorders - Drug Targets Optimal Treatment of Severe Community-Acquired Pneumonia
Current Respiratory Medicine Reviews Identifying the Metabolic Syndrome in Obese Children and Adolescents: Do Age and Definition Matter?
Current Clinical Pharmacology